Moreover, it was previously described that recipients of allogeneic HSCT who develop extensive GvHD are able to generate immune responses against wild-type NPM1 protein [22], while cytotoxic T-lymphocyte (CTL) lines derived from colorectal cancer patients may also recognize normal NPM1 protein sequences [23]. This evidence concerns the gene NPM1 and colorectal cancer.